<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ullman AJ</submitter><funding>National Health and Medical Research Council</funding><pagination>e042475</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8054085</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11(4)</volume><pubmed_abstract>&lt;h4>Introduction&lt;/h4>Peripherally inserted central catheters (PICCs) are vital for the delivery of medical therapies, but up to 30% of PICCs are associated with complications such as deep vein thrombosis or infection. The integration of antimicrobial and hydrophobic catheter materials, and pressure-activated valves, into polyurethane PICCs are innovations designed to prevent infective and/or thrombotic complications.&lt;h4>Methods and analysis&lt;/h4>A multicentre, parallel group, superiority randomised controlled trial with two experimental arms ((1) hydrophobic PICC (with pressure-activated valve); (2) chlorhexidine gluconate-impregnated PICC (with external clamp)) and one control group ((3) conventional polyurethane PICC (with external clamp)). Recruitment of 1098 adult and paediatric patient</pubmed_abstract><journal>BMJ open</journal><pubmed_title>Peripherally Inserted Central catheter iNnovation to reduce Infections and Clots (the PICNIC trial): a randomised controlled trial protocol.</pubmed_title><pmcid>PMC8054085</pmcid><funding_grant_id>APP1157178</funding_grant_id><pubmed_authors>Southam K</pubmed_authors><pubmed_authors>Bulmer A</pubmed_authors><pubmed_authors>Pearch B</pubmed_authors><pubmed_authors>Ullman AJ</pubmed_authors><pubmed_authors>August D</pubmed_authors><pubmed_authors>Mollee P</pubmed_authors><pubmed_authors>Walker R</pubmed_authors><pubmed_authors>Runnegar N</pubmed_authors><pubmed_authors>Chopra V</pubmed_authors><pubmed_authors>Gibson V</pubmed_authors><pubmed_authors>Byrnes J</pubmed_authors><pubmed_authors>Marsh NM</pubmed_authors><pubmed_authors>Kleidon T</pubmed_authors><pubmed_authors>Lee-Archer P</pubmed_authors><pubmed_authors>Coulthard A</pubmed_authors><pubmed_authors>Schults JA</pubmed_authors><pubmed_authors>Harris PNA</pubmed_authors><pubmed_authors>Rickard CM</pubmed_authors><pubmed_authors>Ware RS</pubmed_authors><pubmed_authors>Leema J</pubmed_authors><pubmed_authors>Biles C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Peripherally Inserted Central catheter iNnovation to reduce Infections and Clots (the PICNIC trial): a randomised controlled trial protocol.</name><description>&lt;h4>Introduction&lt;/h4>Peripherally inserted central catheters (PICCs) are vital for the delivery of medical therapies, but up to 30% of PICCs are associated with complications such as deep vein thrombosis or infection. The integration of antimicrobial and hydrophobic catheter materials, and pressure-activated valves, into polyurethane PICCs are innovations designed to prevent infective and/or thrombotic complications.&lt;h4>Methods and analysis&lt;/h4>A multicentre, parallel group, superiority randomised controlled trial with two experimental arms ((1) hydrophobic PICC (with pressure-activated valve); (2) chlorhexidine gluconate-impregnated PICC (with external clamp)) and one control group ((3) conventional polyurethane PICC (with external clamp)). Recruitment of 1098 adult and paediatric patient</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Apr</publication><modification>2026-07-16T06:09:49.454Z</modification><creation>2022-02-09T17:48:34.038Z</creation></dates><accession>S-EPMC8054085</accession><cross_references><pubmed>33853797</pubmed><doi>10.1136/bmjopen-2020-042475</doi></cross_references></HashMap>